Skip to content
Screener

Editas Medicine EDIT Q4 2025 Annual earnings

Reported March 9, 2026 · Before market open

Revenue$24.7MBeat by $16.4M
EPS-$0.06Beat by $0.21
Revenue estimate$8.3M
EPS estimate-$0.27

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$0.21

FAQ

When did Editas Medicine report Q4 2025 earnings?
Editas Medicine (EDIT) reported Q4 2025 earnings on March 9, 2026 before market open.
What were Editas Medicine's Q4 2025 revenue and EPS?
Editas Medicine reported revenue of $24.7M and eps of $-0.06 for Q4 2025.
Did Editas Medicine beat estimates in Q4 2025?
Revenue beat the consensus estimate of $8.3M by $16.4M. EPS beat the consensus estimate of $-0.27 by $0.21.
How did Editas Medicine's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 19.2% from $30.6M a year earlier and eps grew 89.1% from $-0.55.
Where can I find Editas Medicine's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001650664-26-000013) and the 10-K periodic report (0001650664-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.